Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 1999, p. 4788-4797, Vol. 19, No. 7
Experimental Immunology Branch, National Cancer Institute,
National Institutes of Health, Bethesda, Maryland
20892-1360,1 and Department of Molecular
Genetics, University of Texas M. D. Anderson Cancer Center, Houston,
Texas 770302
Received 11 February 1999/Returned for modification 24 March
1999/Accepted 19 April 1999
The tissue-specific expression of major histocompatibility complex
class I genes is determined by a series of upstream regulatory elements, many of which remain ill defined. We now report that a distal
E-box element, located between bp
0270-7306/99/$04.00+0
Upstream Stimulatory Factor Regulates Major Histocompatibility
Complex Class I Gene Expression: the U2
E4 Splice Variant Abrogates
E-Box Activity
309 and
314 upstream of
transcription initiation, acts as a cell type-specific enhancer of
class I promoter activity. The class I E box is very active in a
neuroblastoma cell line, CHP-126, but is relatively inactive in the
HeLa epithelial cell line. The basic helix-loop-helix leucine zipper
proteins upstream stimulatory factor 1 (USF1) and USF2 were shown to
specifically recognize the class I E box, resulting in the activation
of the downstream promoter. Fine mapping of USF1 and USF2
amino-terminal functional domains revealed differences in their
abilities to activate the class I E box. Whereas USF1 contained only an
extended activation domain, USF2 contained both an activation domain
and a negative regulatory region. Surprisingly, the naturally occurring
splice variant of USF2 lacking the exon 4 domain, U2
E4, acted as a
dominant-negative regulator of USF-mediated activation of the class I
promoter. This latter activity is in sharp contrast to the known
ability of U2
E4 to activate the adenovirus major late promoter.
Class I E-box function is correlated with the relative amount of
U2
E4 in a cell, leading to the proposal that U2
E4 modulates class
I E-box activity and may represent one mechanism to fine-tune class I
expression in various tissues.
*
Corresponding author. Mailing address: Experimental
Immunology Branch, National Cancer Institute, National Institutes of
Health, Building 10, Room 4B-17, 10 Center Dr. MSC 1360, Bethesda, MD 20892-1360. Phone: (301) 496-9097. Fax: (301) 480-8499. E-mail: Howcrofk{at}Exchange.nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»